New agreement aims to provide greater access to millions more high-quality tuberculosis (TB) tests for people living in the least developed countries where the need is most urgent. Enables the Global ...
SUNNYVALE, Calif., May 29, 2019 /PRNewswire/ -- Cepheid announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for testing throat and rectal specimens with its ...
SUNNYVALE, Calif., Sept. 29, 2020 /PRNewswire/ -- Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for Xpert ® Xpress SARS-CoV-2 ...
Danaher Corp. posted third-quarter earnings and sales ahead of Wall Street expectations and backed its projection for 2024 sales growth, bolstered by growing demand for its Cepheid medical-testing ...
John Green, a novelist and high-profile YouTuber, is once again leveraging his star power in the global fight to end tuberculosis. His latest target? The diagnostics company Cepheid and the price of ...
Top of the morning to you. And a fine one it is. Lots of sunshine and clear blue skies are once again enveloping the Pharmalot campus, where the official mascots are happily snoozing in their ...
SUNNYVALE, Calif., April 3, 2024 /PRNewswire/ -- Cepheid today announced that Xpert® HIV-1 Qual XC has been awarded World Health Organization (WHO) prequalification. Inclusion on the prequalification ...
Growing preference for rapid, portable DNA testing devices is reshaping diagnostic workflows, especially in remote and ...
(Reuters) - Cepheid Inc said it signed deals with the Bill & Melinda Gates Foundation and three other aid organizations to make its tuberculosis diagnostic kit available at reduced prices in ...
(Reuters) - Molecular diagnostics company Cepheid said it received a grant of up to $3.3 million, co-financed by the Paul G. Allen Family Foundation and the Bill & Melinda Gates Foundation, to develop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback